We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+22.83%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$117B
AUM Growth
+$14.6B
(+14%)
Cap. Flow
-$5.2B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
33.15%
Holding
314
New
18
Increased
56
Reduced
195
Closed
8
Avg Time Held
4.4
years
Top 10 Avg Time Held
4.9
years
Top 20 Avg Time Held
4.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$392M |
| 2 |
T-Mobile US
TMUS
|
+$236M |
| 3 |
Carrier Global
CARR
|
+$88.3M |
| 4 |
Otis Worldwide
OTIS
|
+$78M |
| 5 |
Baidu
BIDU
|
+$77.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$554M |
| 2 |
Eli Lilly
LLY
|
+$354M |
| 3 |
Microsoft
MSFT
|
+$327M |
| 4 |
Texas Instruments
TXN
|
+$225M |
| 5 |
Discover Financial Services
DFS
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.01% |
| 2 | Healthcare | 30.74% |
| 3 | Industrials | 10.56% |
| 4 | Consumer Discretionary | 9.5% |
| 5 | Financials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.12T
| $6.51B | 5.58% |
39,627,957
-2,307,345
| -6% | -$354M |
2013 Q2
28 quarters
|
|
|
2
Microsoft
MSFT
$4.01T
| $4.87B | 4.17% |
23,906,408
-1,803,770
| -7% | -$327M |
2013 Q2
28 quarters
|
|
|
3
Adobe
ADBE
$97.9B
| $4.79B | 4.11% |
11,002,288
-1,495,502
| -12% | -$554M |
2013 Q2
28 quarters
|
|
4
Amgen
AMGN
$236B
| $4.24B | 3.64% |
17,962,930
-517,160
| -3% | -$118M |
2013 Q2
28 quarters
|
|
5
Biogen
BIIB
$34.9B
| $4.18B | 3.59% |
15,631,932
-334,057
| -2% | -$100M |
2013 Q2
28 quarters
|
|
|
6
Texas Instruments
TXN
$256B
| $3.35B | 2.87% |
26,355,293
-1,929,525
| -7% | -$225M |
2013 Q2
28 quarters
|
|
7
Alibaba
BABA
$276B
| $2.85B | 2.45% |
13,211,926
-585,300
| -4% | -$122M |
2014 Q3
23 quarters
|
|
8
AstraZeneca
AZN
$259B
| $2.84B | 2.44% |
26,830,869
-1,489,792
| -5% | -$154M |
2015 Q3
19 quarters
|
|
9
Micron Technology
MU
$1.05T
| $2.65B | 2.28% |
51,464,679
-2,002,730
| -4% | -$94.4M |
2013 Q2
28 quarters
|
|
10
Southwest Airlines
LUV
$20B
| $2.36B | 2.03% |
69,190,098
+1,294,290
| +2% | +$41.1M |
2013 Q2
28 quarters
|
|
11
Alphabet (Google) Class A
GOOGL
$4.27T
| $2.32B | 1.99% |
32,717,360
-1,707,780
| -5% | -$115M |
2015 Q3
19 quarters
|
|
12
Sony
SONY
$144B
| $2.28B | 1.96% |
164,896,775
-10,503,850
| -6% | -$136M |
2013 Q2
28 quarters
|
|
13
BioMarin Pharmaceuticals
BMRN
$10.9B
| $2.21B | 1.89% |
17,883,971
+74,204
| +0.4% | +$7.37M |
2013 Q2
28 quarters
|
|
14
Novartis
NVS
$286B
| $2.03B | 1.74% |
23,267,270
-761,070
| -3% | -$65.7M |
2013 Q2
28 quarters
|
|
15
Alphabet (Google) Class C
GOOG
$4.22T
| $2B | 1.72% |
28,316,460
-2,600,040
| -8% | -$175M |
2013 Q2
28 quarters
|
|
16
KLA
KLAC
$228B
| $1.95B | 1.67% |
100,052,890
-3,322,550
| -3% | -$56.8M |
2013 Q2
28 quarters
|
|
17
Qualcomm
QCOM
$191B
| $1.93B | 1.66% |
21,184,833
-2,231,995
| -10% | -$179M |
2013 Q2
28 quarters
|
|
18
FedEx
FDX
$69.9B
| $1.9B | 1.63% |
13,583,039
-148,850
| -1% | -$18.7M |
2013 Q2
28 quarters
|
|
19
Thermo Fisher Scientific
TMO
$257B
| $1.72B | 1.47% |
4,740,441
-104,910
| -2% | -$35.2M |
2013 Q4
26 quarters
|
|
20
JPMorgan Chase
JPM
$891B
| $1.63B | 1.4% |
17,348,490
-2,089,595
| -11% | -$198M |
2015 Q1
21 quarters
|
|
21
Intel
INTC
$506B
| $1.47B | 1.27% |
24,643,461
-707,600
| -3% | -$42.3M |
2013 Q2
28 quarters
|
|
22
Boston Scientific
BSX
$64.1B
| $1.46B | 1.26% |
41,681,905
-630,120
| -1% | -$22.7M |
2013 Q2
28 quarters
|
|
23
Tesla
TSLA
$1.44T
| $1.42B | 1.22% |
19,777,725
-3,406,875
| -15% | -$184M |
2013 Q2
28 quarters
|
|
24
NetApp
NTAP
$42.1B
| $1.32B | 1.13% |
29,726,938
-992,300
| -3% | -$42.6M |
2013 Q2
28 quarters
|
|
25
Bristol-Myers Squibb
BMY
$124B
| $1.21B | 1.04% |
20,623,795
-1,097,360
| -5% | -$65.6M |
2017 Q1
13 quarters
|
|
Similar funds
Primecap Management's Q2 2020 Portfolio in Review
As of Q2 2020, Primecap Management held 314 positions worth $117B, up 14% from $102B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $5.2B in Q2 2020, closing 8 positions and reducing 195 holdings. Its most notable exit was Sprint Corporation, an estimated $215M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in ASML worth $460M.
- Primecap Management's largest Q2 2020 buy was ASML: 1,249,987 shares worth $460M.
- Primecap Management added most to T-Mobile US in Q2 2020, an estimated $236M increase.
- Primecap Management's biggest Q2 2020 reduction was Adobe, cutting an estimated $554M.
- Primecap Management fully exited Sprint Corporation in Q2 2020, selling an estimated $215M.
- Primecap Management's ten largest holdings make up 33% of its $117B portfolio in Q2 2020.
- Primecap Management opened 18 new positions and closed 8 in Q2 2020.
- Primecap Management's portfolio value rose 14% quarter-over-quarter to $117B.
Based on Primecap Management's 13F filing for Q2 2020, filed 13 Aug 2020.